NEA Management Company’s Mirum Pharmaceuticals MIRM Stock Holding History

NEA Management Company’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,186,243	Closed	-$69.1M	–	46
2023 Q3	$69.1M	Hold	2,186,243	–	–	5.34%	6
2023 Q2	$56.6M	Sell	2,186,243 -2,000,000	-48%	-$53.2M	4.32%	7
2023 Q1	$101M	Hold	4,186,243	–	–	6.95%	4
2022 Q4	$81.6M	Sell	4,186,243 -1,558	-0%	-$30.8K	4.59%	7
2022 Q3	$88M	Hold	4,187,801	–	–	4.39%	9
2022 Q2	$81.5M	Hold	4,187,801	–	–	4.19%	7
2022 Q1	$92.2M	Hold	4,187,801	–	–	2.66%	9
2021 Q4	$66.8M	Hold	4,187,801	–	–	1.35%	14
2021 Q3	$83.4M	Hold	4,187,801	–	–	0.99%	14
2021 Q2	$72.4M	Hold	4,187,801	–	–	0.94%	16
2021 Q1	$83M	Hold	4,187,801	–	–	1.86%	16
2020 Q4	$73.1M	Hold	4,187,801	–	–	1.93%	18
2020 Q3	$80.7M	Hold	4,187,801	–	–	3.42%	13
2020 Q2	$81.5M	Hold	4,187,801	–	–	3.28%	14
2020 Q1	$58.6M	Hold	4,187,801	–	–	3.06%	14
2019 Q4	$103M	Hold	4,187,801	–	–	4.86%	10
2019 Q3	$42.1M	Buy	+4,187,801	New	+$51.4M	3.49%	8

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

NEA Management Company's MIRM Position: Q4 2023 in Review

NEA Management Company sold out of Mirum Pharmaceuticals (MIRM) in Q4 2023, closing a stake of 2,186,243 shares — an estimated $69.1M sold.

NEA Management Company first reported a position in MIRM in Q3 2019 and held it in 17 quarters. The position peaked at $103M in Q4 2019. 187 funds tracked by Wall St. Rank hold MIRM as of Q4 2023.

NEA Management Company reported no remaining Mirum Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
NEA Management Company sold 2,186,243 Mirum Pharmaceuticals shares in Q4 2023, an estimated $69.1M.
NEA Management Company first reported a position in Mirum Pharmaceuticals in Q3 2019 and held it in 17 quarters.
NEA Management Company's Mirum Pharmaceuticals position peaked at $103M in Q4 2019.
187 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2023.

Based on NEA Management Company's 13F filing for Q4 2023, filed 14 Feb 2024.